Search research articles
Contact Us
Filters
Showing results (131-140 of 706) with videos related to
Page
of 71
Sort By:
Diabetes Research and Clinical Practice
|
July 21, 2005
Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol
Richard J Woodman, David A Playford, Gerald F Watts
Journal of Clinical Lipidology
|
September 25, 2024
Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease
Angela Burvill, Gerald F Watts, Richard Norman, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity
|
February 10, 2025
An overview of persistent chylomicronemia: much more than meets the eye
Miriam Larouche, Gerald F Watts, Christie Ballantyne, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 14, 2022
A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
Natalie C Ward, Dick C Chan, Gerald F Watts
Journal of Clinical and Diagnostic Research : JCDR
|
July 21, 2016
Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?
Nandhini Rangarajan, Shanthi Balasubramanian, Jing Pang, et al.
Diabetes, Obesity & Metabolism
|
April 20, 2019
Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies
Natalie C Ward, Michael M Page, Gerald F Watts
Diabetes & Vascular Disease Research
|
July 27, 2007
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus
Sandra J Hamilton, Gerard T Chew, Gerald F Watts
Current Opinion in Cardiology
|
February 26, 2020
The brave new world of genetic testing in the management of the dyslipidaemias
Hapizah Md Nawawi, Yung-An Chua, Gerald F Watts
Frontiers in Cardiovascular Medicine
|
December 12, 2022
Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
Natalie C Ward, Christopher M Reid, Gerald F Watts
Atherosclerosis
|
October 2, 2018
Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part
Tom Brett, Nadeem Qureshi, Samuel Gidding, et al.
Page
of 71
Search research articles
Search
Showing results (131-140 of 706) with videos related to
Sort By:
Page
of 71
Diabetes Research and Clinical Practice
|
July 21, 2005
Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol
Richard J Woodman, David A Playford, Gerald F Watts
Journal of Clinical Lipidology
|
September 25, 2024
Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease
Angela Burvill, Gerald F Watts, Richard Norman, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity
|
February 10, 2025
An overview of persistent chylomicronemia: much more than meets the eye
Miriam Larouche, Gerald F Watts, Christie Ballantyne, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 14, 2022
A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
Natalie C Ward, Dick C Chan, Gerald F Watts
Journal of Clinical and Diagnostic Research : JCDR
|
July 21, 2016
Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?
Nandhini Rangarajan, Shanthi Balasubramanian, Jing Pang, et al.
Diabetes, Obesity & Metabolism
|
April 20, 2019
Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies
Natalie C Ward, Michael M Page, Gerald F Watts
Diabetes & Vascular Disease Research
|
July 27, 2007
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus
Sandra J Hamilton, Gerard T Chew, Gerald F Watts
Current Opinion in Cardiology
|
February 26, 2020
The brave new world of genetic testing in the management of the dyslipidaemias
Hapizah Md Nawawi, Yung-An Chua, Gerald F Watts
Frontiers in Cardiovascular Medicine
|
December 12, 2022
Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
Natalie C Ward, Christopher M Reid, Gerald F Watts
Atherosclerosis
|
October 2, 2018
Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part
Tom Brett, Nadeem Qureshi, Samuel Gidding, et al.
Page
of 71